NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anto Biosciences

Anto Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://anto.bio/

Last Round

VC Round

Jun 13, 2026

Total Funding Raised

$1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Anto Biosciences is a biotechnology company that develops a multimodal foundation model for microbial communities to predict drug toxicity and efficacy across diverse populations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Foundation

Keywords

foundation modelsfrontier ai labgut microbiomedrug discoverymetagenomic profilingprecision medicineclinical trial optimizationdrug toxicity predictionbio-aicomputational biologyai drug discoverymicrobiome therapeuticsmultimodal aidata sparsificationin silico drug screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anto Biosciences Comparables

Compare Anto Biosciences with similar companies based on industry and business-model similarity.

Anto Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nexilico, Inc.
86%
Kanvas Biosciences
66%
Basecamp Research
63%

Anto Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 13, 2026
SeedOct 13, 2025
AcceleratorSep 1, 2025

Anto Biosciences Investors

Notable investors and investment history

Anto Biosciences investors
InvestorRounds
Y CombinatorAccelerator, Seed
C10 LabsSeed
Tekedia CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 209% MoM, reaching 5.3K.

Anto Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anto Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anto Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2025
Last FundingJun 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.